Trial of LU AF82422 in participants with multiple system atrophy (H-56562)
Description
Content
Interventional, randomized, double-blind, placebo-controlled, optional open-label extension trial of LU AF82422 in participants with multiple system atrophy
The purpose of this clinical trial is to find out whether a potential new treatment, the trial drug, Lu AF82422, is safe and effective in people living with MSA.
The purpose of this trial is to find out whether a potential new treatment, the trial drug, Lu AF82422, is safe and effective in people living with MSA. This trial will compare the effects of the trial drug, Lu AF82422, to placebo (inactive medication). Both the trial drug and placebo will be given as an infusion. Researchers use a placebo to see if a trial drug works better or is safer than not taking anything at all. The main question the researchers want to answer is: Will treatment with Lu AF82422 slow the progression of MSA disease over time?
Contact
Phone 1: 713–798–5989
IRB: H-56562
Status:
Active
Created:
